398 related articles for article (PubMed ID: 25248036)
1. Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation.
Ghoussaini M; Edwards SL; Michailidou K; Nord S; Cowper-Sal Lari R; Desai K; Kar S; Hillman KM; Kaufmann S; Glubb DM; Beesley J; Dennis J; Bolla MK; Wang Q; Dicks E; Guo Q; Schmidt MK; Shah M; Luben R; Brown J; Czene K; Darabi H; Eriksson M; Klevebring D; Bojesen SE; Nordestgaard BG; Nielsen SF; Flyger H; Lambrechts D; Thienpont B; Neven P; Wildiers H; Broeks A; Van't Veer LJ; Th Rutgers EJ; Couch FJ; Olson JE; Hallberg E; Vachon C; Chang-Claude J; Rudolph A; Seibold P; Flesch-Janys D; Peto J; Dos-Santos-Silva I; Gibson L; Nevanlinna H; Muranen TA; Aittomäki K; Blomqvist C; Hall P; Li J; Liu J; Humphreys K; Kang D; Choi JY; Park SK; Noh DY; Matsuo K; Ito H; Iwata H; Yatabe Y; Guénel P; Truong T; Menegaux F; Sanchez M; Burwinkel B; Marme F; Schneeweiss A; Sohn C; Wu AH; Tseng CC; Van Den Berg D; Stram DO; Benitez J; Zamora MP; Perez JI; Menéndez P; Shu XO; Lu W; Gao YT; Cai Q; Cox A; Cross SS; Reed MW; Andrulis IL; Knight JA; Glendon G; Tchatchou S; Sawyer EJ; Tomlinson I; Kerin MJ; Miller N; Haiman CA; Henderson BE; Schumacher F; Le Marchand L; Lindblom A; Margolin S; Teo SH; Yip CH; Lee DS; Wong TY; Hooning MJ; Martens JW; Collée JM; van Deurzen CH; Hopper JL; Southey MC; Tsimiklis H; Kapuscinski MK; Shen CY; Wu PE; Yu JC; Chen ST; Alnæs GG; Borresen-Dale AL; Giles GG; Milne RL; McLean C; Muir K; Lophatananon A; Stewart-Brown S; Siriwanarangsan P; Hartman M; Miao H; Buhari SA; Teo YY; Fasching PA; Haeberle L; Ekici AB; Beckmann MW; Brenner H; Dieffenbach AK; Arndt V; Stegmaier C; Swerdlow A; Ashworth A; Orr N; Schoemaker MJ; García-Closas M; Figueroa J; Chanock SJ; Lissowska J; Simard J; Goldberg MS; Labrèche F; Dumont M; Winqvist R; Pylkäs K; Jukkola-Vuorinen A; Brauch H; Brüning T; Koto YD; Radice P; Peterlongo P; Bonanni B; Volorio S; Dörk T; Bogdanova NV; Helbig S; Mannermaa A; Kataja V; Kosma VM; Hartikainen JM; Devilee P; Tollenaar RA; Seynaeve C; Van Asperen CJ; Jakubowska A; Lubinski J; Jaworska-Bieniek K; Durda K; Slager S; Toland AE; Ambrosone CB; Yannoukakos D; Sangrajrang S; Gaborieau V; Brennan P; McKay J; Hamann U; Torres D; Zheng W; Long J; Anton-Culver H; Neuhausen SL; Luccarini C; Baynes C; Ahmed S; Maranian M; Healey CS; González-Neira A; Pita G; Alonso MR; Alvarez N; Herrero D; Tessier DC; Vincent D; Bacot F; de Santiago I; Carroll J; Caldas C; Brown MA; Lupien M; Kristensen VN; Pharoah PD; Chenevix-Trench G; French JD; Easton DF; Dunning AM; ;
Nat Commun; 2014 Sep; 4():4999. PubMed ID: 25248036
[TBL] [Abstract][Full Text] [Related]
2. An intergenic risk locus containing an enhancer deletion in 2q35 modulates breast cancer risk by deregulating IGFBP5 expression.
Wyszynski A; Hong CC; Lam K; Michailidou K; Lytle C; Yao S; Zhang Y; Bolla MK; Wang Q; Dennis J; Hopper JL; Southey MC; Schmidt MK; Broeks A; Muir K; Lophatananon A; Fasching PA; Beckmann MW; Peto J; Dos-Santos-Silva I; Sawyer EJ; Tomlinson I; Burwinkel B; Marme F; Guénel P; Truong T; Bojesen SE; Nordestgaard BG; González-Neira A; Benitez J; Neuhausen SL; Brenner H; Dieffenbach AK; Meindl A; Schmutzler RK; Brauch H; ; Nevanlinna H; Khan S; Matsuo K; Ito H; Dörk T; Bogdanova NV; Lindblom A; Margolin S; Mannermaa A; Kosma VM; ; ; Wu AH; Van Den Berg D; Lambrechts D; Wildiers H; Chang-Claude J; Rudolph A; Radice P; Peterlongo P; Couch FJ; Olson JE; Giles GG; Milne RL; Haiman CA; Henderson BE; Dumont M; Teo SH; Wong TY; Kristensen V; Zheng W; Long J; Winqvist R; Pylkäs K; Andrulis IL; Knight JA; Devilee P; Seynaeve C; García-Closas M; Figueroa J; Klevebring D; Czene K; Hooning MJ; van den Ouweland AM; Darabi H; Shu XO; Gao YT; Cox A; Blot W; Signorello LB; Shah M; Kang D; Choi JY; Hartman M; Miao H; Hamann U; Jakubowska A; Lubinski J; Sangrajrang S; McKay J; Toland AE; Yannoukakos D; Shen CY; Wu PE; Swerdlow A; Orr N; Simard J; Pharoah PD; Dunning AM; Chenevix-Trench G; Hall P; Bandera E; Amos C; Ambrosone C; Easton DF; Cole MD
Hum Mol Genet; 2016 Sep; 25(17):3863-3876. PubMed ID: 27402876
[TBL] [Abstract][Full Text] [Related]
3. Unbiased analysis of potential targets of breast cancer susceptibility loci by Capture Hi-C.
Dryden NH; Broome LR; Dudbridge F; Johnson N; Orr N; Schoenfelder S; Nagano T; Andrews S; Wingett S; Kozarewa I; Assiotis I; Fenwick K; Maguire SL; Campbell J; Natrajan R; Lambros M; Perrakis E; Ashworth A; Fraser P; Fletcher O
Genome Res; 2014 Nov; 24(11):1854-68. PubMed ID: 25122612
[TBL] [Abstract][Full Text] [Related]
4. Functional annotation of the 2q35 breast cancer risk locus implicates a structural variant in influencing activity of a long-range enhancer element.
Baxter JS; Johnson N; Tomczyk K; Gillespie A; Maguire S; Brough R; Fachal L; Michailidou K; Bolla MK; Wang Q; Dennis J; Ahearn TU; Andrulis IL; Anton-Culver H; Antonenkova NN; Arndt V; Aronson KJ; Augustinsson A; Becher H; Beckmann MW; Behrens S; Benitez J; Bermisheva M; Bogdanova NV; Bojesen SE; Brenner H; Brucker SY; Cai Q; Campa D; Canzian F; Castelao JE; Chan TL; Chang-Claude J; Chanock SJ; Chenevix-Trench G; Choi JY; Clarke CL; ; Colonna S; Conroy DM; Couch FJ; Cox A; Cross SS; Czene K; Daly MB; Devilee P; Dörk T; Dossus L; Dwek M; Eccles DM; Ekici AB; Eliassen AH; Engel C; Fasching PA; Figueroa J; Flyger H; Gago-Dominguez M; Gao C; García-Closas M; García-Sáenz JA; Ghoussaini M; Giles GG; Goldberg MS; González-Neira A; Guénel P; Gündert M; Haeberle L; Hahnen E; Haiman CA; Hall P; Hamann U; Hartman M; Hatse S; Hauke J; Hollestelle A; Hoppe R; Hopper JL; Hou MF; ; ; Ito H; Iwasaki M; Jager A; Jakubowska A; Janni W; John EM; Joseph V; Jung A; Kaaks R; Kang D; Keeman R; Khusnutdinova E; Kim SW; Kosma VM; Kraft P; Kristensen VN; Kubelka-Sabit K; Kurian AW; Kwong A; Lacey JV; Lambrechts D; Larson NL; Larsson SC; Le Marchand L; Lejbkowicz F; Li J; Long J; Lophatananon A; Lubiński J; Mannermaa A; Manoochehri M; Manoukian S; Margolin S; Matsuo K; Mavroudis D; Mayes R; Menon U; Milne RL; Mohd Taib NA; Muir K; Muranen TA; Murphy RA; Nevanlinna H; O'Brien KM; Offit K; Olson JE; Olsson H; Park SK; Park-Simon TW; Patel AV; Peterlongo P; Peto J; Plaseska-Karanfilska D; Presneau N; Pylkäs K; Rack B; Rennert G; Romero A; Ruebner M; Rüdiger T; Saloustros E; Sandler DP; Sawyer EJ; Schmidt MK; Schmutzler RK; Schneeweiss A; Schoemaker MJ; Shah M; Shen CY; Shu XO; Simard J; Southey MC; Stone J; Surowy H; Swerdlow AJ; Tamimi RM; Tapper WJ; Taylor JA; Teo SH; Teras LR; Terry MB; Toland AE; Tomlinson I; Truong T; Tseng CC; Untch M; Vachon CM; van den Ouweland AMW; Wang SS; Weinberg CR; Wendt C; Winham SJ; Winqvist R; Wolk A; Wu AH; Yamaji T; Zheng W; Ziogas A; Pharoah PDP; Dunning AM; Easton DF; Pettitt SJ; Lord CJ; Haider S; Orr N; Fletcher O
Am J Hum Genet; 2021 Jul; 108(7):1190-1203. PubMed ID: 34146516
[TBL] [Abstract][Full Text] [Related]
5. A functional variant rs4442975 modulating FOXA1-binding affinity does not influence the risk or progression of breast cancer in Chinese Han population.
Zhang Y; Li Y; Jiang S; Chen W; Lou J; Ke J; Li J; Zhu Y; Gong Y; Yang Y; Tian J; Peng X; Zou D; Gong J; Chang J; Miao X; Zhong R
Oncotarget; 2016 Dec; 7(49):81691-81697. PubMed ID: 27835577
[TBL] [Abstract][Full Text] [Related]
6. Evidence that the 5p12 Variant rs10941679 Confers Susceptibility to Estrogen-Receptor-Positive Breast Cancer through FGF10 and MRPS30 Regulation.
Ghoussaini M; French JD; Michailidou K; Nord S; Beesley J; Canisus S; Hillman KM; Kaufmann S; Sivakumaran H; Moradi Marjaneh M; Lee JS; Dennis J; Bolla MK; Wang Q; Dicks E; Milne RL; Hopper JL; Southey MC; Schmidt MK; Broeks A; Muir K; Lophatananon A; Fasching PA; Beckmann MW; Fletcher O; Johnson N; Sawyer EJ; Tomlinson I; Burwinkel B; Marme F; Guénel P; Truong T; Bojesen SE; Flyger H; Benitez J; González-Neira A; Alonso MR; Pita G; Neuhausen SL; Anton-Culver H; Brenner H; Arndt V; Meindl A; Schmutzler RK; Brauch H; Hamann U; Tessier DC; Vincent D; Nevanlinna H; Khan S; Matsuo K; Ito H; Dörk T; Bogdanova NV; Lindblom A; Margolin S; Mannermaa A; Kosma VM; ; Wu AH; Van Den Berg D; Lambrechts D; Floris G; Chang-Claude J; Rudolph A; Radice P; Barile M; Couch FJ; Hallberg E; Giles GG; Haiman CA; Le Marchand L; Goldberg MS; Teo SH; Yip CH; Borresen-Dale AL; ; Zheng W; Cai Q; Winqvist R; Pylkäs K; Andrulis IL; Devilee P; Tollenaar RA; García-Closas M; Figueroa J; Hall P; Czene K; Brand JS; Darabi H; Eriksson M; Hooning MJ; Koppert LB; Li J; Shu XO; Zheng Y; Cox A; Cross SS; Shah M; Rhenius V; Choi JY; Kang D; Hartman M; Chia KS; Kabisch M; Torres D; Luccarini C; Conroy DM; Jakubowska A; Lubinski J; Sangrajrang S; Brennan P; Olswold C; Slager S; Shen CY; Hou MF; Swerdlow A; Schoemaker MJ; Simard J; Pharoah PD; Kristensen V; Chenevix-Trench G; Easton DF; Dunning AM; Edwards SL
Am J Hum Genet; 2016 Oct; 99(4):903-911. PubMed ID: 27640304
[TBL] [Abstract][Full Text] [Related]
7. Fine-scale mapping of the FGFR2 breast cancer risk locus: putative functional variants differentially bind FOXA1 and E2F1.
Meyer KB; O'Reilly M; Michailidou K; Carlebur S; Edwards SL; French JD; Prathalingham R; Dennis J; Bolla MK; Wang Q; de Santiago I; Hopper JL; Tsimiklis H; Apicella C; Southey MC; Schmidt MK; Broeks A; Van 't Veer LJ; Hogervorst FB; Muir K; Lophatananon A; Stewart-Brown S; Siriwanarangsan P; Fasching PA; Lux MP; Ekici AB; Beckmann MW; Peto J; Dos Santos Silva I; Fletcher O; Johnson N; Sawyer EJ; Tomlinson I; Kerin MJ; Miller N; Marme F; Schneeweiss A; Sohn C; Burwinkel B; Guénel P; Truong T; Laurent-Puig P; Menegaux F; Bojesen SE; Nordestgaard BG; Nielsen SF; Flyger H; Milne RL; Zamora MP; Arias JI; Benitez J; Neuhausen S; Anton-Culver H; Ziogas A; Dur CC; Brenner H; Müller H; Arndt V; Stegmaier C; Meindl A; Schmutzler RK; Engel C; Ditsch N; Brauch H; Brüning T; Ko YD; ; Nevanlinna H; Muranen TA; Aittomäki K; Blomqvist C; Matsuo K; Ito H; Iwata H; Yatabe Y; Dörk T; Helbig S; Bogdanova NV; Lindblom A; Margolin S; Mannermaa A; Kataja V; Kosma VM; Hartikainen JM; Chenevix-Trench G; ; ; Wu AH; Tseng CC; Van Den Berg D; Stram DO; Lambrechts D; Thienpont B; Christiaens MR; Smeets A; Chang-Claude J; Rudolph A; Seibold P; Flesch-Janys D; Radice P; Peterlongo P; Bonanni B; Bernard L; Couch FJ; Olson JE; Wang X; Purrington K; Giles GG; Severi G; Baglietto L; McLean C; Haiman CA; Henderson BE; Schumacher F; Le Marchand L; Simard J; Goldberg MS; Labrèche F; Dumont M; Teo SH; Yip CH; Phuah SY; Kristensen V; Grenaker Alnæs G; Børresen-Dale AL; Zheng W; Deming-Halverson S; Shrubsole M; Long J; Winqvist R; Pylkäs K; Jukkola-Vuorinen A; Kauppila S; Andrulis IL; Knight JA; Glendon G; Tchatchou S; Devilee P; Tollenaar RA; Seynaeve CM; García-Closas M; Figueroa J; Chanock SJ; Lissowska J; Czene K; Darabi H; Eriksson K; Hooning MJ; Martens JW; van den Ouweland AM; van Deurzen CH; Hall P; Li J; Liu J; Humphreys K; Shu XO; Lu W; Gao YT; Cai H; Cox A; Reed MW; Blot W; Signorello LB; Cai Q; Pharoah PD; Ghoussaini M; Harrington P; Tyrer J; Kang D; Choi JY; Park SK; Noh DY; Hartman M; Hui M; Lim WY; Buhari SA; Hamann U; Försti A; Rüdiger T; Ulmer HU; Jakubowska A; Lubinski J; Jaworska K; Durda K; Sangrajrang S; Gaborieau V; Brennan P; McKay J; Vachon C; Slager S; Fostira F; Pilarski R; Shen CY; Hsiung CN; Wu PE; Hou MF; Swerdlow A; Ashworth A; Orr N; Schoemaker MJ; Ponder BA; Dunning AM; Easton DF
Am J Hum Genet; 2013 Dec; 93(6):1046-60. PubMed ID: 24290378
[TBL] [Abstract][Full Text] [Related]
8. Genetic variation in IGFBP2 and IGFBP5 is associated with breast cancer in populations of African descent.
Garner CP; Ding YC; John EM; Ingles SA; Olopade OI; Huo D; Adebamowo C; Ogundiran T; Neuhausen SL
Hum Genet; 2008 Apr; 123(3):247-55. PubMed ID: 18210156
[TBL] [Abstract][Full Text] [Related]
9. Fine-mapping identifies two additional breast cancer susceptibility loci at 9q31.2.
Orr N; Dudbridge F; Dryden N; Maguire S; Novo D; Perrakis E; Johnson N; Ghoussaini M; Hopper JL; Southey MC; Apicella C; Stone J; Schmidt MK; Broeks A; Van't Veer LJ; Hogervorst FB; Fasching PA; Haeberle L; Ekici AB; Beckmann MW; Gibson L; Aitken Z; Warren H; Sawyer E; Tomlinson I; Kerin MJ; Miller N; Burwinkel B; Marme F; Schneeweiss A; Sohn C; Guénel P; Truong T; Cordina-Duverger E; Sanchez M; Bojesen SE; Nordestgaard BG; Nielsen SF; Flyger H; Benitez J; Zamora MP; Arias Perez JI; Menéndez P; Anton-Culver H; Neuhausen SL; Brenner H; Dieffenbach AK; Arndt V; Stegmaier C; Hamann U; Brauch H; Justenhoven C; Brüning T; Ko YD; Nevanlinna H; Aittomäki K; Blomqvist C; Khan S; Bogdanova N; Dörk T; Lindblom A; Margolin S; Mannermaa A; Kataja V; Kosma VM; Hartikainen JM; Chenevix-Trench G; Beesley J; Lambrechts D; Moisse M; Floris G; Beuselinck B; Chang-Claude J; Rudolph A; Seibold P; Flesch-Janys D; Radice P; Peterlongo P; Peissel B; Pensotti V; Couch FJ; Olson JE; Slettedahl S; Vachon C; Giles GG; Milne RL; McLean C; Haiman CA; Henderson BE; Schumacher F; Le Marchand L; Simard J; Goldberg MS; Labrèche F; Dumont M; Kristensen V; Alnæs GG; Nord S; Borresen-Dale AL; Zheng W; Deming-Halverson S; Shrubsole M; Long J; Winqvist R; Pylkäs K; Jukkola-Vuorinen A; Grip M; Andrulis IL; Knight JA; Glendon G; Tchatchou S; Devilee P; Tollenaar RA; Seynaeve CM; Van Asperen CJ; Garcia-Closas M; Figueroa J; Chanock SJ; Lissowska J; Czene K; Darabi H; Eriksson M; Klevebring D; Hooning MJ; Hollestelle A; van Deurzen CH; Kriege M; Hall P; Li J; Liu J; Humphreys K; Cox A; Cross SS; Reed MW; Pharoah PD; Dunning AM; Shah M; Perkins BJ; Jakubowska A; Lubinski J; Jaworska-Bieniek K; Durda K; Ashworth A; Swerdlow A; Jones M; Schoemaker MJ; Meindl A; Schmutzler RK; Olswold C; Slager S; Toland AE; Yannoukakos D; Muir K; Lophatananon A; Stewart-Brown S; Siriwanarangsan P; Matsuo K; Ito H; Iwata H; Ishiguro J; Wu AH; Tseng CC; Van Den Berg D; Stram DO; Teo SH; Yip CH; Kang P; Ikram MK; Shu XO; Lu W; Gao YT; Cai H; Kang D; Choi JY; Park SK; Noh DY; Hartman M; Miao H; Lim WY; Lee SC; Sangrajrang S; Gaborieau V; Brennan P; Mckay J; Wu PE; Hou MF; Yu JC; Shen CY; Blot W; Cai Q; Signorello LB; Luccarini C; Bayes C; Ahmed S; Maranian M; Healey CS; González-Neira A; Pita G; Alonso MR; Álvarez N; Herrero D; Tessier DC; Vincent D; Bacot F; Hunter DJ; Lindstrom S; Dennis J; Michailidou K; Bolla MK; Easton DF; dos Santos Silva I; Fletcher O; Peto J; ; ;
Hum Mol Genet; 2015 May; 24(10):2966-84. PubMed ID: 25652398
[TBL] [Abstract][Full Text] [Related]
10. Fine-scale mapping of the 5q11.2 breast cancer locus reveals at least three independent risk variants regulating MAP3K1.
Glubb DM; Maranian MJ; Michailidou K; Pooley KA; Meyer KB; Kar S; Carlebur S; O'Reilly M; Betts JA; Hillman KM; Kaufmann S; Beesley J; Canisius S; Hopper JL; Southey MC; Tsimiklis H; Apicella C; Schmidt MK; Broeks A; Hogervorst FB; van der Schoot CE; Muir K; Lophatananon A; Stewart-Brown S; Siriwanarangsan P; Fasching PA; Ruebner M; Ekici AB; Beckmann MW; Peto J; dos-Santos-Silva I; Fletcher O; Johnson N; Pharoah PD; Bolla MK; Wang Q; Dennis J; Sawyer EJ; Tomlinson I; Kerin MJ; Miller N; Burwinkel B; Marme F; Yang R; Surowy H; Guénel P; Truong T; Menegaux F; Sanchez M; Bojesen SE; Nordestgaard BG; Nielsen SF; Flyger H; González-Neira A; Benitez J; Zamora MP; Arias Perez JI; Anton-Culver H; Neuhausen SL; Brenner H; Dieffenbach AK; Arndt V; Stegmaier C; Meindl A; Schmutzler RK; Brauch H; Ko YD; Brüning T; ; Nevanlinna H; Muranen TA; Aittomäki K; Blomqvist C; Matsuo K; Ito H; Iwata H; Tanaka H; Dörk T; Bogdanova NV; Helbig S; Lindblom A; Margolin S; Mannermaa A; Kataja V; Kosma VM; Hartikainen JM; ; Wu AH; Tseng CC; Van Den Berg D; Stram DO; Lambrechts D; Zhao H; Weltens C; van Limbergen E; Chang-Claude J; Flesch-Janys D; Rudolph A; Seibold P; Radice P; Peterlongo P; Barile M; Capra F; Couch FJ; Olson JE; Hallberg E; Vachon C; Giles GG; Milne RL; McLean C; Haiman CA; Henderson BE; Schumacher F; Le Marchand L; Simard J; Goldberg MS; Labrèche F; Dumont M; Teo SH; Yip CH; See MH; Cornes B; Cheng CY; Ikram MK; Kristensen V; ; Zheng W; Halverson SL; Shrubsole M; Long J; Winqvist R; Pylkäs K; Jukkola-Vuorinen A; Kauppila S; Andrulis IL; Knight JA; Glendon G; Tchatchou S; Devilee P; Tollenaar RA; Seynaeve C; Van Asperen CJ; García-Closas M; Figueroa J; Chanock SJ; Lissowska J; Czene K; Klevebring D; Darabi H; Eriksson M; Hooning MJ; Hollestelle A; Martens JW; Collée JM; Hall P; Li J; Humphreys K; Shu XO; Lu W; Gao YT; Cai H; Cox A; Cross SS; Reed MW; Blot W; Signorello LB; Cai Q; Shah M; Ghoussaini M; Kang D; Choi JY; Park SK; Noh DY; Hartman M; Miao H; Lim WY; Tang A; Hamann U; Torres D; Jakubowska A; Lubinski J; Jaworska K; Durda K; Sangrajrang S; Gaborieau V; Brennan P; McKay J; Olswold C; Slager S; Toland AE; Yannoukakos D; Shen CY; Wu PE; Yu JC; Hou MF; Swerdlow A; Ashworth A; Orr N; Jones M; Pita G; Alonso MR; Álvarez N; Herrero D; Tessier DC; Vincent D; Bacot F; Luccarini C; Baynes C; Ahmed S; Healey CS; Brown MA; Ponder BA; Chenevix-Trench G; Thompson DJ; Edwards SL; Easton DF; Dunning AM; French JD
Am J Hum Genet; 2015 Jan; 96(1):5-20. PubMed ID: 25529635
[TBL] [Abstract][Full Text] [Related]
11. Functional analysis of a breast cancer-associated FGFR2 single nucleotide polymorphism using zinc finger mediated genome editing.
Robbez-Masson LJ; Bödör C; Jones JL; Hurst HC; Fitzgibbon J; Hart IR; Grose RP
PLoS One; 2013; 8(11):e78839. PubMed ID: 24265722
[TBL] [Abstract][Full Text] [Related]
12. Correlation between the DNA methylation and gene expression of IGFBP5 in breast cancer.
Karabulut S; Kaya Z; Amuran GG; Peker I; Özmen T; Gūllūoḡlu BM; Kaya H; Erzik C; Ōzer A; Akkiprik M
Breast Dis; 2016; 36(4):123-131. PubMed ID: 27612043
[TBL] [Abstract][Full Text] [Related]
13. Fine-mapping of a novel premenopausal breast cancer susceptibility locus at Chr4q31.22 in Caucasian women and validation in African and Chinese women.
Kumaran M; Ghosh S; Joy AA; Mackey JR; Cass CE; Zheng W; Yasui Y; Damaraju S
Int J Cancer; 2020 Mar; 146(5):1219-1229. PubMed ID: 31087647
[TBL] [Abstract][Full Text] [Related]
14. KDM6B Counteracts EZH2-Mediated Suppression of
Wang W; Lim KG; Feng M; Bao Y; Lee PL; Cai Y; Chen Y; Zhang H; Marzese D; Hoon DSB; Yu Q
Mol Cancer Ther; 2018 Sep; 17(9):1973-1983. PubMed ID: 29925528
[TBL] [Abstract][Full Text] [Related]
15. Integrative functional genomics identifies regulatory genetic variant modulating RAB31 expression and altering susceptibility to breast cancer.
Zhang Y; Yang B; Cheng X; Liu L; Zhu Y; Gong Y; Yang Y; Tian J; Peng X; Zou D; Yang L; Mei S; Wang X; Lou J; Ke J; Li J; Gong J; Chang J; Yuan P; Zhong R
Mol Carcinog; 2018 Dec; 57(12):1845-1854. PubMed ID: 30182384
[TBL] [Abstract][Full Text] [Related]
16. Biological effects and regulation of IGFBP5 in breast cancer.
Dittmer J
Front Endocrinol (Lausanne); 2022; 13():983793. PubMed ID: 36093095
[TBL] [Abstract][Full Text] [Related]
17. Genome-Wide Association Studies (GWAS) breast cancer susceptibility loci in Arabs: susceptibility and prognostic implications in Tunisians.
Shan J; Mahfoudh W; Dsouza SP; Hassen E; Bouaouina N; Abdelhak S; Benhadjayed A; Memmi H; Mathew RA; Aigha II; Gabbouj S; Remadi Y; Chouchane L
Breast Cancer Res Treat; 2012 Oct; 135(3):715-24. PubMed ID: 22910930
[TBL] [Abstract][Full Text] [Related]
18. Integrative functional genomics identifies an enhancer looping to the SOX9 gene disrupted by the 17q24.3 prostate cancer risk locus.
Zhang X; Cowper-Sal lari R; Bailey SD; Moore JH; Lupien M
Genome Res; 2012 Aug; 22(8):1437-46. PubMed ID: 22665440
[TBL] [Abstract][Full Text] [Related]
19. Expression level of insulin-like growth factor binding protein 5 mRNA is a prognostic factor for breast cancer.
Li X; Cao X; Li X; Zhang W; Feng Y
Cancer Sci; 2007 Oct; 98(10):1592-6. PubMed ID: 17651454
[TBL] [Abstract][Full Text] [Related]
20. Genetic variations of DNA bindings of FOXA1 and co-factors in breast cancer susceptibility.
Wen W; Chen Z; Bao J; Long Q; Shu XO; Zheng W; Guo X
Nat Commun; 2021 Sep; 12(1):5318. PubMed ID: 34518541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
